A High-Throughput Screen Targeting Malaria Transmission Stages Opens New Avenues for Drug Development

被引:89
作者
Buchholz, Kathrin [1 ]
Burke, Thomas A. [1 ]
Williamson, Kim C. [3 ]
Wiegand, Roger C. [2 ]
Wirth, Dyann F. [1 ,2 ,3 ]
Marti, Matthias [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[2] Broad Inst, Cambridge, MA USA
[3] Loyola Univ, Dept Biol, Chicago, IL 60626 USA
关键词
PLASMODIUM-FALCIPARUM MALARIA; IN-VITRO; CONTINUOUS CULTURE; SULFADOXINE-PYRIMETHAMINE; GAMETOCYTE FORMATION; SEXUAL DEVELOPMENT; IDENTIFICATION; CHLOROQUINE; PARASITES; PROTEINS;
D O I
10.1093/infdis/jir037
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A major goal of the worldwide malaria eradication program is the reduction and eventual elimination of malaria transmission. All currently available antimalarial compounds were discovered on the basis of their activity against the asexually reproducing red blood cell stages of the parasite, which are responsible for the morbidity and mortality of human malaria. Resistance against these compounds is widespread, and there is an urgent need for novel approaches to reduce the emergence of resistance to new antimalarials as they are introduced. We have established and validated the first high-throughput assay targeting the red blood cell parasite stage required for transmission, the sexually reproducing gametocyte. This assay will permit identification of compounds specifically targeting the transmission stages in addition to the asexual stage parasites. Such stage-specific compounds may be used in a combination therapy, reducing the emergence of resistance by blocking transmission of resistant parasites that may be selected in a patient.
引用
收藏
页码:1445 / 1453
页数:9
相关论文
共 44 条
[1]   Comparison of SYBR Green I-, PicoGreen-, and [3H]-hypoxanthine-based assays for in vitro antimalarial screening of plants from Nigerian ethnomedicine [J].
Abiodun, Oyindamola O. ;
Gbotosho, Grace O. ;
Ajaiyeoba, Edith O. ;
Happi, Christian T. ;
Hofer, Sandra ;
Wittlin, Sergio ;
Sowunmi, Akin ;
Brun, Reto ;
Oduola, Ayoade M. J. .
PARASITOLOGY RESEARCH, 2010, 106 (04) :933-939
[2]   High-throughput Plasmodium falciparum growth assay for malaria drug discovery [J].
Baniecki, Mary Lynn ;
Wirth, Dyann F. ;
Clardy, Jon .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) :716-723
[3]  
Basco LK, 1999, ANN TROP MED PARASIT, V93, P179, DOI 10.1080/00034989958663
[4]   Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development [J].
Beutler, Ernest ;
Duparc, Stephan .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (04) :779-789
[5]   CONDITIONS FAVORING GAMETOCYTOGENESIS IN THE CONTINUOUS CULTURE OF PLASMODIUM-FALCIPARUM [J].
BROCKELMAN, CR .
JOURNAL OF PROTOZOOLOGY, 1982, 29 (03) :454-458
[6]   COMMITMENT OF THE MALARIA PARASITE PLASMODIUM-FALCIPARUM TO SEXUAL AND ASEXUAL DEVELOPMENT [J].
BRUCE, MC ;
ALANO, P ;
DUTHIE, S ;
CARTER, R .
PARASITOLOGY, 1990, 100 :191-200
[7]   Antimalarial drugs and the mosquito transmission of Plasmodium [J].
Butcher, GA .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1997, 27 (09) :975-987
[8]   An alternative to serum for cultivation of Plasmodium falciparum in vitro [J].
Cranmer, SL ;
Magowan, C ;
Liang, J ;
Coppel, RL ;
Cooke, BM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1997, 91 (03) :363-365
[9]   Tafenoquine: a promising new antimalarial agent [J].
Crockett, Maryanne ;
Kain, Kevin C. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (05) :705-715
[10]   Distinct physiological states of Plasmodium falciparum in malaria-infected patients [J].
Daily, J. P. ;
Scanfeld, D. ;
Pochet, N. ;
Le Roch, K. ;
Plouffe, D. ;
Kamal, M. ;
Sarr, O. ;
Mboup, S. ;
Ndir, O. ;
Wypij, D. ;
Levasseur, K. ;
Thomas, E. ;
Tamayo, P. ;
Dong, C. ;
Zhou, Y. ;
Lander, E. S. ;
Ndiaye, D. ;
Wirth, D. ;
Winzeler, E. A. ;
Mesirov, J. P. ;
Regev, A. .
NATURE, 2007, 450 (7172) :1091-U15